Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
297 GBX | 0.00% | +0.68% | -15.74% |
05-03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
04-02 | MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | CI |
Evolution of the average Target Price on MaxCyte, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering MaxCyte, Inc.
BTIG | |
Craig-Hallum | |
Stifel Nicolaus |
EPS Revisions
- Stock Market
- Equities
- MXCT Stock
- Consensus MaxCyte, Inc.